RecensMedical, Inc. (KOSDAQ:394420)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,250
+490 (5.02%)
At close: Sep 4, 2026

RecensMedical Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
6,5218,8296,2595,771281.76
Revenue Growth
4.17%41.05%8.47%1948.03%-
Gross Profit
3,4724,3091,3433,00691.91
Operating Income
-11,742-10,640-14,161-12,584-20,245
Net Income
-11,046-19,119-7,844-7,572-40,994
Earnings Per Share
-1125.66-2890.00-2292.00-2282.91-12412.11
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
13,672987.5110,2962,57116,434
Total Debt
5,976804.72617.61778.61973.09
Net Cash (Debt)
7,696182.799,6791,79315,460
Net Cash Growth
-20.49%-98.11%439.95%-88.41%-
Net Cash Per Share
784.2827.632828.22540.424681.06

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-11,266-8,594-9,733-13,278-22,022
Capital Expenditures
-1,136-760.59-482.58-251.62-717.77
Free Cash Flow
-12,402-9,354-10,215-13,530-22,740
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
53.25%48.81%21.46%52.09%32.62%
Operating Margin
-180.08%-120.52%-226.24%-218.07%-7185.17%
Pretax Margin
-169.40%-216.56%-125.31%-131.22%-14549.34%
Profit Margin
-169.40%-216.56%-125.31%-131.22%-14549.34%
FCF Margin
-190.19%-105.95%-163.20%-234.47%-8070.77%